MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 113 filers reported holding MERUS N V in Q2 2023. The put-call ratio across all filers is 1.53 and the average weighting 0.9%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,424,000 | 19.47% |
| BVF INC/IL | 7,285,071 | $152,185,000 | 5.71% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 244,713 | $5,112,000 | 2.79% |
| Burrage Capital Management LLC | 130,683 | $2,730,000 | 2.21% |
| MPM BioImpact LLC | 700,879 | $14,641,000 | 1.84% |
| Sofinnova Investments, Inc. | 1,311,039 | $27,388,000 | 1.65% |
| Octagon Capital Advisors LP | 200,000 | $4,178,000 | 1.57% |
| Boxer Capital, LLC | 1,900,000 | $39,691,000 | 1.35% |
| DAFNA Capital Management LLC | 157,841 | $3,297,000 | 0.78% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,113,706 | $23,265,000 | 0.34% |